BioRestorative Therapies, Inc.
BRTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 175% | 21.7% | 160.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 93% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,834.4% | -10,268.7% | -15,645.2% | -56,997.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,239.2% | -7,145.2% | -11,037% | -96,311.5% |
| EPS Diluted | -1.16 | -2.47 | -3.65 | -37.3 |
| % Growth | 53% | 32.3% | 90.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |